相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quality of Life Analysis in Patients With RAS Wild-Type Metastatic Colorectal Cancer Treated With First-Line Cetuximab Plus Chemotherapy
Kensei Yamaguchi et al.
CLINICAL COLORECTAL CANCER (2017)
RAS testing in metastatic colorectal cancer: advances in Europe
J. Han J. M. Van Krieken et al.
VIRCHOWS ARCHIV (2016)
A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers
Marije Oosterhoff et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2016)
Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer
Robert T. Jones et al.
UROLOGIC CLINICS OF NORTH AMERICA (2016)
Cost-effectiveness of RAS screening before monoclonal antibodies therapy in metastatic colorectal cancer based on FIRE3 Study
Feng Wen et al.
CANCER BIOLOGY & THERAPY (2015)
Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer
J. Randolph Hecht et al.
CANCER TREATMENT REVIEWS (2015)
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer
C. Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2015)
Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer
Masahiro Inoue et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer
Dominik P. Modest et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Personalized Approaches to Gastrointestinal Cancers Importance of Integrating Genomic Information to Guide Therapy
Jin He et al.
SURGICAL CLINICS OF NORTH AMERICA (2015)
COST EFFECTIVENESS OF CETUXIMAB IN FIRST LINE TREATMENT OF RAS WILD-TYPE METASTATIC COLORECTAL CANCER IN THE UK: A SUMMARY OF ECONOMIC ANA LYSES SUBMITTED TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
A. Hnoosh et al.
VALUE IN HEALTH (2015)
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
Giuseppe Bronte et al.
ONCOTARGET (2015)
Cost Estimates and Economic Implications of Expanded RAS Testing in Metastatic Colorectal Cancer
Sheetal M. Kircher et al.
ONCOLOGIST (2015)
Economic evaluations of personalized medicine: existing challenges and current developments
Fatiha H. Shabaruddin et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2015)
Clinical potential of gene mutations in lung cancer
Miranda B. Carper et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2014)
Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer
Ajay S. Behl et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Stratified medicine and reimbursement issues
Hans-Joerg Fugel et al.
FRONTIERS IN PHARMACOLOGY (2012)
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study
C. Bokemeyer et al.
ANNALS OF ONCOLOGY (2011)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
COST-EFFECTIVENESS OF CETUXIMAB AND BEVACIZUMAB IN THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) FOR PATIENTS WITH KRAS WILD-TYPE TUMOURS IN THE UNITED KINGDOM
Y. Samyshkin et al.
VALUE IN HEALTH (2011)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Targeting signal transduction pathways in colorectal cancer - More than skin deep
SJ Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
分享论文
